|Day's Range||35.21 - 35.45|
|52 Week Range||23.00 - 36.49|
|PE Ratio (TTM)||18.30|
|Dividend & Yield||0.86 (2.42%)|
|1y Target Est||N/A|
The luxury homebuilder topped Q2 earnings and sales growth forecasts. But shares of Toll Bros. and several other builders reversed to close lower, in part due to plunging new-home sales data.
Health care technology giant Koninklijke Philips has reached a deal to buy Twin Cities medical-device maker RespirTech for an undisclosed amount. Roseville-based RespirTech makes the inCourage line of airway-clearance vests, which treat chronic lung conditions such as cystic fibrosis. The deal will let Philips expand further into the market for treating conditions such as chronic obstructive pulmonary disease, the company said in a news release.
The adoption of connected technologies in healthcare remains limited and is progressing slowly, despite the promise they hold for cutting medical costs by preventing illness, the chief executive of Philips said on Wednesday. The conclusion is one of several derived from a major survey the company is publishing this week, but the question is not academic for Philips: it has staked its future on the healthcare market after spinning off its lighting operations last year, and it expects connected care to be one of the major pillars of its future growth.